---
title: "Anteris Technologies Plans Major Share Placement to Raise Capital"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/273172774.md"
description: "Anteris Technologies Global Corp. plans to raise capital through a proposed placement of up to 55,652,173 shares, targeting an issue date of January 23, 2026. This move aims to strengthen the company's financial position and support its operational initiatives, though it may lead to shareholder dilution. The latest analyst rating for Anteris Technologies (AU:AVR) is a Buy, with a price target of A$10.00. The company specializes in innovative cardiovascular solutions within the medtech sector."
datetime: "2026-01-21T04:23:32.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/273172774.md)
  - [en](https://longbridge.com/en/news/273172774.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/273172774.md)
generator: "portal-rs"
---

# Anteris Technologies Plans Major Share Placement to Raise Capital

### Claim 50% Off TipRanks Premium

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

Anteris Technologies ( (AU:AVR) ) has issued an update.

Anteris Technologies Global Corp. has notified the ASX of a proposed placement involving the issue of up to 55,652,173 shares of common stock, with a targeted issue date of 23 January 2026. The capital raising via this substantial new share issuance is expected to bolster the company’s financial position and support its ongoing operational and strategic initiatives, with implications for shareholder dilution but also potentially enhancing its capacity to advance product development and market expansion within the medtech sector.

The most recent analyst rating on (AU:AVR) stock is a Buy with a A$10.00 price target. To see the full list of analyst forecasts on Anteris Technologies stock, see the AU:AVR Stock Forecast page.

**More about Anteris Technologies**

Anteris Technologies Global Corp., listed on the ASX under the code AVR, operates in the medical technology sector, focusing on innovative cardiovascular solutions and related healthcare technologies for global markets.

**Average Trading Volume:** 23,102

**Technical Sentiment Signal:** Sell

Learn more about AVR stock on TipRanks’ Stock Analysis page.

### Related Stocks

- [AVR.AU](https://longbridge.com/en/quote/AVR.AU.md)

## Related News & Research

- [Anteris Announces Results for the First Quarter of 2026 | AVR Stock News](https://longbridge.com/en/news/286166978.md)
- [Anteris Ends v2vmedtech Development Agreement, Limits Exposure](https://longbridge.com/en/news/284655464.md)
- [Tom Lee Sees ETH 'Easily' Hitting $10,000, Says BitMine Could Buy More Than 5%](https://longbridge.com/en/news/296958709.md)
- [BMO Just Named Nvidia a Top Pick as It Initiates Coverage. What This Means for NVDA Stock.](https://longbridge.com/en/news/296944132.md)
- [Nike Stock Drop Hits Founder’s Net Worth: Phil Knight Nears Exit of Top 100 Richest](https://longbridge.com/en/news/296957879.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**